USP7 is frequently overexpressed in NB cell lines and patient tumors and has been associated with aggressive tumor behavior and poor clinical outcomes, further suggesting that USP7 inhibitors are likely to be effective against NB cells and tumors. The gene discussed is USP7; the disease is neuroblastoma.